Genopsy Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Genopsy General Information

Description

Operator of a biotechnology company intended to cure cancer-related diseases. The company's platform develops nanowires that can perform circulating tumor, DNA isolation, and specific mutation analysis simultaneously in the body fluids, enabling cancer patients to get early detection and treatment for cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 400-12 Yangcheon-ro
  • Number 811-815
  • Seoul, Gangnam-gu 07573
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 400-12 Yangcheon-ro
  • Number 811-815
  • Seoul, Gangnam-gu 07573
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genopsy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 10-Sep-2022 Completed Out of Business
1. Early Stage VC (Series A) 19-Jun-2019 Completed Generating Revenue
To view Genopsy’s complete valuation and funding history, request access »

Genopsy Patents

Genopsy Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022528278-A Cancer diagnosis method using cfdna Active 05-Apr-2019
JP-7782835-B2 Cancer diagnosis method using cfdna Active 05-Apr-2019
EP-3950962-A2 Method for diagnosing cancer using cfdna Pending 05-Apr-2019
EP-3950962-A4 Method for diagnosing cancer using cfdna Pending 05-Apr-2019
JP-2026021394-A Method for diagnosing cancer using cfdna Pending 05-Apr-2019 C12Q1/6886
To view Genopsy’s complete patent history, request access »

Genopsy Investments (1)

Genopsy’s most recent deal was a Seed Round with Ichrogene for . The deal was made on 15-Jan-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ichrogene 15-Jan-2020 Seed Round Enterprise Systems (Healthcare)
To view Genopsy’s complete investments history, request access »

Genopsy FAQs

  • When was Genopsy founded?

    Genopsy was founded in 2018.

  • Where is Genopsy headquartered?

    Genopsy is headquartered in Seoul, South Korea.

  • What industry is Genopsy in?

    Genopsy’s primary industry is Diagnostic Equipment.

  • Is Genopsy a private or public company?

    Genopsy is a Private company.

  • What is Genopsy’s current revenue?

    The current revenue for Genopsy is .

  • How much funding has Genopsy raised over time?

    Genopsy has raised $8.44M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process